Video Experimental Relacionado
Updated: Aug 11, 2026

15:33
Adenoviral Transduction of Naive CD4 T Cells to Study Treg Differentiation
Published on: August 13, 2013
La activación de la transcripción por la proteína E1a del adenovirus
1Department of Biochemistry and Molecular Biology, Harvard University, Cambridge, Massachusetts 02138.
Nature
|March 2, 1989
Resumen
La proteína del adenovirus E1a actúa como un activador celular al unirse a proteínas unidas al ADN y estimular la transcripción génica. Esta doble función es crucial para regular la expresión génica viral y celular.
Área de la Ciencia:
- Biología Molecular Biología Molecular
- Virología Virología.
- Reglamento genético Reglamento genético.
Sus antecedentes:
- Se sabe que la proteína Adenovirus E1a estimula la transcripción de genes virales y celulares.
- Los activadores celulares suelen poseer dominios funcionales distintos.
Objetivo del estudio:
- Para dilucidar los mecanismos funcionales de la proteína E1a del adenovirus como activador de la transcripción.
- Identificar las funciones específicas de E1a en la regulación génica.
Principales métodos:
- El estudio probablemente involucró técnicas de biología molecular para analizar las interacciones proteína-ADN y la actividad transcripcional.
- Los experimentos pueden haberse centrado en identificar regiones funcionales distintas dentro de la proteína E1a.
Principales resultados:
- La proteína del adenovirus E1a exhibe dos funciones clave características de los activadores celulares.
- Una función implica dirigir E1a al promotor, potencialmente a través de la interacción con las proteínas unidas al ADN.
- La segunda función es una región activadora que estimula la transcripción tras la unión.
Conclusiones:
- La proteína del adenovirus E1a funciona como un típico activador de la transcripción celular.
- El mecanismo dual de E1a de orientación de promotores y activación transcripcional es esencial para su papel en la regulación génica.
Videos de Conceptos Relacionados
Gene Therapy
Gene therapy is a technique where a gene is inserted into a person’s cells to prevent or treat a serious disease. The added gene may be a healthy version of the gene that is mutated in the patient, or it could be a different gene that inactivates or compensates for the patient’s disease-causing gene. For example, in patients with severe combined immunodeficiency (SCID) due to a mutation in the gene for the enzyme adenosine deaminase, a functioning version of the gene can be inserted. The...
RNA Polymerase II Accessory Proteins
Proteins that regulate transcription can do so either via direct contact with RNA Polymerase or through indirect interactions facilitated by adaptors, mediators, histone-modifying proteins, and nucleosome remodelers. Direct interactions to activate transcription is seen in bacteria as well as in some eukaryotic genes. In these cases, upstream activation sequences are adjacent to the promoters, and the activator proteins interact directly with the transcriptional machinery. For example, in...
Eukaryotic Transcription Activators
Transcription activators are proteins that promote the transcription of genes from DNA to RNA. In most cases, these proteins contain two separate domains ‒ a domain that binds to DNA and a domain for activating transcription; however, in some cases, a single domain is responsible for both binding and activation of transcription, as seen in the glucocorticoid receptor and MyoD.
The binding domains are capable of recognizing and interacting with regulatory sequences on the DNA. These domains are...
The binding domains are capable of recognizing and interacting with regulatory sequences on the DNA. These domains are...
Eukaryotic Transcription Inhibitors
Certain biochemical processes, such as embryonic development and cell growth regulation, depend on the repression of specific genes. DNA binding proteins known as eukaryotic transcription inhibitors regulate the repression of gene expression in eukaryotes. The presence of these inhibitors at the required location and time in the cell is triggered by the presence of hormones and additional signals from other cells.
Eukaryotic transcription inhibitors usually contain two distinct domains, a DNA...
Eukaryotic transcription inhibitors usually contain two distinct domains, a DNA...

